États-Unis - anglais - NLM (National Library of Medicine)

perrigo new york inc - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - levocetirizine dihydrochloride is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. pediatric use information in pediatric patients (age 2 to 5 years) with seasonal allergic rhinitis is approved for ucb inc.’s levocetirizine dihydrochloride drug product. however, due to ucb inc.’s marketing exclusivity rights; this drug product is not labeled for such use in those pediatric patients. levocetirizine dihydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. pediatric use information in pediatric patients (age 6 months to 5 years) with perennial allergic rhinitis is approved for ucb inc.’s levocetirizine dihydrochloride drug product. however, due to ucb inc.’s marketing exclusivity rights; this drug product is not labeled for such use in those pediatric patients. levocetirizine dihydrochloride is indicated for the treatment of the uncomplicated

États-Unis - anglais - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 0.5 mg in 1 ml - levocetirizine dihydrochloride oral solution is indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. levocetirizine dihydrochloride oral solution is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)] . patients with end-stage renal disease (clcr <10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects,

États-Unis - anglais - NLM (National Library of Medicine)

apotex corp. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 0.5 mg in 1 ml - levocetirizine dihydrochloride oral solution is indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. levocetirizine dihydrochloride oral solution is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride oral solution is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride oral solution, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2) ]. patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks o

États-Unis - anglais - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24) - cetirizine hydrochloride syrup is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age. symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing. cetirizine hydrochloride syrup is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age. it significantly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus. cetirizine hydrochloride is contraindicated in those patients with a known hypersensitivity to it or any of its ingredients or hydroxyzine. there is no information to indicate that abuse or dependency occurs with cetirizine hydrochloride.

États-Unis - anglais - NLM (National Library of Medicine)

dispensing solutions, inc. - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant

États-Unis - anglais - NLM (National Library of Medicine)

proficient rx lp - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant

États-Unis - anglais - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - levocetirizine dihydrochloride - oral tablet - 5mg